MANAGEMENT   |   PARTNERS   |   ADVISORS

KEN ITRATO
Corporate, Securities, and Strategic Transactions Law

 

Ken Itrato is a highly experienced corporate and transactional attorney focused on venture capital, private equity, mergers and acquisitions, strategic financings, licensing, and complex commercial transactions across the life sciences, biotechnology, software, SaaS, internet, engineering, medical technology, and advanced technology sectors. Based in Boston, he advises entrepreneurs, venture backed companies, investors, family offices, and both privately held and publicly traded organizations on a broad range of strategic, operational, financing, and commercialization matters involving high growth and innovation driven enterprises.

Over the course of his career, Ken has advised on transactions involving hundreds of millions of dollars in venture capital and private equity financings, as well as mergers and acquisitions valued in the billions. His practice includes sophisticated strategic transactions involving biotechnology, therapeutics, diagnostics, medical devices, digital health, software platforms, and emerging technologies, with extensive experience supporting companies through all stages of formation, growth, financing, commercialization, and strategic expansion.

Ken currently serves as a Partner at Crowell & Moring, a nationally recognized international law firm with approximately 600 attorneys and one of the leading legal platforms serving life sciences, healthcare, technology, government, and complex corporate transactional clients. Crowell & Moring has developed a significant national reputation across life sciences, intellectual property, healthcare, litigation, regulatory, and transactional practices, representing innovative companies ranging from emerging growth ventures to major multinational enterprises.

Prior to joining Crowell & Moring, Ken was a founding principal of Faber Daeufer & Itrato PC, a specialized life sciences and technology transactional law firm recognized for advising biotechnology, therapeutics, healthcare, pharmaceutical, and emerging technology companies on sophisticated financing, licensing, partnering, and strategic commercialization matters. The firm developed a strong reputation within the biotechnology and life sciences sectors for representing highly innovative companies, venture backed enterprises, investors, and strategic industry participants operating at the forefront of medical and technological innovation.

Throughout his career, Ken has developed deep expertise structuring and negotiating mission critical transactions involving intellectual property, platform technologies, strategic alliances, research and development collaborations, manufacturing arrangements, commercialization agreements, distribution structures, joint ventures, equity financings, debt financings, mergers and acquisitions, and cross border strategic partnerships. His work has included extensive representation involving therapeutics companies, biopharmaceutical organizations, diagnostics businesses, digital health platforms, medical device companies, software ventures, and advanced engineering enterprises.

Ken has also maintained longstanding involvement within leading entrepreneurial, venture capital, and university innovation ecosystems. He has served as a mentor for the MIT $100K Entrepreneurship Competition, widely regarded as one of the most prestigious university startup competitions in the world, as well as the ICE business plan competition. In addition, he has advised Cornell University’s Center for Technology Licensing (CCTEC) and has been actively involved with the Cornell University Life Sciences community, the Cornell Entrepreneurial Network, and the Dartmouth Entrepreneurial Network.

He has additionally served on the National Venture Capital Association (NVCA) model legal documents drafting committee, contributing to the development of financing documentation standards widely utilized throughout the venture capital and startup ecosystem. His experience working across venture financing, strategic transactions, and technology commercialization has made him a trusted advisor to founders, executive teams, boards of directors, institutional investors, venture capital firms, and innovation focused enterprises operating in highly technical and rapidly evolving industries.

Earlier in his legal career, Ken practiced general corporate and transactional law at both AmLaw 50 and AmLaw 200 law firms, providing him with extensive experience across sophisticated corporate transactions, governance matters, financing structures, and strategic business operations involving both emerging growth and institutional clients.

Ken earned his Bachelor of Arts degree from Cornell University and his Juris Doctor, Order of the Coif, from Georgetown University Law Center, reflecting academic distinction in legal scholarship. He is admitted to practice law in the Commonwealth of Massachusetts.